-+ 0.00%
-+ 0.00%
-+ 0.00%

Peptide (4587) 3Q operating loss narrowed (▲2.867 billion yen 1-9 months consolidated IFRS), 2026/12 forecast (4.6 billion yen)

NIKKEI QUICK·11/11/2026 06:40:35

Please log in to view news